A MYC-STAMBPL1-TOE1 positive feedback loop mediates EGFR stability in hepatocellular carcinoma
Open Access
- 9 October 2024
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 43 (10) , 114812
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970551, 81970726)
- National Key Research and Development Program of China (2021YFC2103900)
This publication has 59 references indexed in Scilit:
- Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent MechanismHepatology, 2021
- Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradationCancer Letters, 2019
- Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor SignalingCancer Cell, 2018
- Emerging functions of the EGFR in cancerMolecular Oncology, 2017
- Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratificationHepatology, 2014
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer TherapeuticsCancer Cell, 2014
- Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYCCell Reports, 2012
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in miceHepatology, 2011
- ERBB2 is a target for USP8-mediated deubiquitinationCellular Signalling, 2011
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006